SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Anticipation is building around Altimmune as the company prepares to release clinical data for its MASH and obesity candidate, with potential institutional accumulation driving recent gains. The community is buzzing about the possibility of a significant short squeeze and speculation around a potential buyout, drawing comparisons to other successful biotech firms. Positive results could unlock substantial upside, while disappointing data may lead to a pullback, setting the stage for a volatile trading day.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending strongly, fueled by bullish sentiment and discussions around its potential to challenge Nvidia in the AI chip market. Community members are actively discussing price targets, with many anticipating a continued upward trajectory towards previous highs and beyond. Recent news, including analyst upgrades and partnerships, appear to be reinforcing confidence in AMD's long-term growth prospects.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

The 4CHAN.X crypto is trending as community members highlight its deep roots within internet culture and meme creation. Some users point to its connection to the 4chan platform and its potential for generating wealth, emphasizing the importance of community and shared belief. There's a strong focus on the coin's potential within the meme coin sector, drawing comparisons to established cryptocurrencies.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is trending with community members actively discussing its potential for significant gains and comparing it to other meme coins like DOGE and SHIB. A segment of the community is focused on technical analysis, identifying potential buying opportunities and debating future price movements. There is also discussion around the broader meme coin market and its correlation with Bitcoin's movements.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending due to anticipation surrounding upcoming oral data and the initiation of Phase 3 trials for its weight loss drug, VK2735, with investors weighing its potential against competitors like ALT. Community discussions revolve around the high short interest, potential for a short squeeze, and buyout possibilities amidst the ongoing obesity drug race. Some traders are expressing concerns about trial timelines and management strategy, while others maintain a bullish outlook on the stock's long-term potential.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is trending as traders discuss its potential in the AI server market and debate whether a short squeeze is brewing, especially with tailwinds from NVDA and AMD. Community members are focused on key price levels, recent partnerships, and the stock's volatile history. Bullish sentiment seems to be growing as analysts issue positive ratings, generating active discussions about potential catalysts and future growth prospects.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending as investors closely monitor its performance in the AI-driven HBM market, especially after Key Bank raised its price target, signaling a shift away from the cyclical DRAM market. Community members are actively discussing Micron's partnerships with companies like Nvidia and AMD, anticipating a bullish run driven by record-breaking quarterly statistics and strong guidance. Additionally, many are evaluating whether current valuations fully reflect future growth potential, considering it within the context of the broader semiconductor sector's performance.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending as investors react to cost-cutting measures like shutting down its auto arm and relying on AI for marketing, sparking debate about its turnaround strategy and ability to compete with rivals like AMD and Nvidia. Community discussions revolve around Intel's potential for growth, its current valuation, and whether it can capitalize on opportunities in AI and domestic chip production. Technical analysis suggests key support and resistance levels, with some anticipating a breakout if certain price points are reached.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amid a battle between bulls and bears, with community members highlighting the high short interest and potential for a squeeze. Discussions revolve around Novo Nordisk's accusations against Hims and the potential impact on future earnings, as well as speculation around the partnership's end. Despite the volatility, some investors express long-term bullish sentiment, citing the company's innovative approach and potential for disruption in the healthcare industry.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is trending following positive Phase 2b trial results for its eczema drug, rezpeg, with analysts issuing bullish price targets. The community is discussing the potential for a short squeeze and buyout, while also weighing the possibility of an upcoming offering. Some traders are drawing comparisons to similar setups in other stocks, anticipating a multi-day run.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<a href="https://stocktwits.com/symbol/BEL.NSE/news">Shares of Bharat Electronics Limited</a> (BEL) are demonstrating strong technical momentum as it approaches its quarterly results on May 19, according to SEBI-registered analyst Sameer Pande.<stembedurl>https://stocktwits.com/sameerpande/message/614850980</stembedurl>The analyst identified positive breakout patterns on the daily and weekly charts, which led him to recommend buying the stock at present market levels.&nbsp;At the time of writing, Bharat Electronics Limited shares were trading at ₹362.75, up ₹12.35 or 3.5%.Sameer Pande advised traders to set a stop loss at ₹315 based on closing prices while maintaining an investment period of two months.The Navratna PSU BEL is well-known for producing sophisticated electronic products for the Indian military.&nbsp;By extending its operations into homeland security, smart cities, and energy storage sectors, the company strengthens its position for growth in domains that match India’s strategic objectives.Recent geopolitical shifts, including the India-Pakistan ceasefire after Operation Sindoor, have spotlighted the defence sector.&nbsp;Defence stocks surged after the ceasefire between India and Pakistan, prompting the Nifty India Defence index to rise by almost 16% since April 22.&nbsp;Jefferies has selected BEL as one of its top three defence picks in the current market environment due to its robust fundamentals and promising sector potential.The stock has risen 23.4% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Bharat Electronics Shares Show Strong Technical Momentum Ahead Of Q1 Results: SEBI RA Sameer Pande Recommends ‘Buy’

The stock has gained over 23% in 2025, supported by positive breakout patterns and sector tailwinds.

Bharat Electronics Shares Show Strong Technical Momentum Ahead Of Q1 Results: SEBI RA Sameer Pande Recommends ‘Buy’

Latest News